Richard Ferrari
CIK: 0001034413
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 2, 2026BEAT
HeartBeam, Inc.
Award(A)DirectRestricted Stock Units
125K shares- - Oct 2, 2026BEAT
HeartBeam, Inc.
Award(A)DirectStock Option (Right to Buy)
125K shares- - Oct 2, 2026BEAT
HeartBeam, Inc.
Award(A)DirectRestricted Stock Units
90.6K shares- - Jul 31, 2026TNON
Tenon Medical, Inc.
Exercise(M)Direct64.5K shares- - Jun 5, 2026LUNG
Pulmonx Corp
Award(A)Direct40K shares- - Apr 16, 2026BEAT
HeartBeam, Inc.
Purchase(P)Direct57.5K shares at avg. $0.80$46K - Apr 16, 2026BEAT
HeartBeam, Inc.
Purchase(P)Direct62.5K shares at avg. $0.80$50K - Feb 9, 2026BEAT
HeartBeam, Inc.
Award(A)Direct50K shares- - Jan 1, 2026TNON
Tenon Medical, Inc.
Exercise(M)Direct64.5K shares- - Oct 13, 2025TNON
Tenon Medical, Inc.
Award(A)DirectRestricted Stock Units
129K shares- - Jun 12, 2025LUNG
Pulmonx Corp
Sale(S)Direct8K shares at avg. $3.16$25K - Jun 2, 2025LUNG
Pulmonx Corp
Award(A)Direct37.2K shares- - Feb 14, 2025BEAT
HeartBeam, Inc.
Purchase(P)Direct29.4K shares at avg. $1.70$50K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  BEAT HeartBeam, Inc. | Award(A) Restricted Stock Units | 125,000 | - | - | Direct |
| Oct 2, 2026 | BEAT HeartBeam, Inc. | Award(A) Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Oct 2, 2026 | BEAT HeartBeam, Inc. | Award(A) Restricted Stock Units | 90,625 | - | - | Direct |
| Jul 31, 2026 |  TNON Tenon Medical, Inc. | Exercise(M) | 64,479 | - | $0 | Direct |
| Jun 5, 2026 |  LUNG Pulmonx Corp | Award(A) | 40,000 | - | $0 | Direct |
| Apr 16, 2026 | BEAT HeartBeam, Inc. | Purchase(P) | 57,500 | $0.80 | $46,000 | Direct |
| Apr 16, 2026 | BEAT HeartBeam, Inc. | Purchase(P) | 62,500 | $0.80 | $50,000 | Direct |
| Feb 9, 2026 | BEAT HeartBeam, Inc. | Award(A) | 50,000 | - | $0 | Direct |
| Jan 1, 2026 | TNON Tenon Medical, Inc. | Exercise(M) | 64,478 | - | $0 | Direct |
| Oct 13, 2025 | TNON Tenon Medical, Inc. | Award(A) Restricted Stock Units | 128,957 | - | - | Direct |
| Jun 12, 2025 | LUNG Pulmonx Corp | Sale(S) | 8,000 | $3.16 | $25,280 | Direct |
| Jun 2, 2025 | LUNG Pulmonx Corp | Award(A) | 37,153 | - | - | Direct |
| Feb 14, 2025 | BEAT HeartBeam, Inc. | Purchase(P) | 29,412 | $1.70 | $50,000 | Direct |
1-13 of 13 transactions
About Ferrari Richard
Ferrari Richard (SEC CIK 0001034413) files insider reports with the SEC as Director of HeartBeam, Inc. (BEAT), Director of Tenon Medical, Inc. (TNON) and Director of Pulmonx Corp (LUNG).
Signal8 holds 12 ownership filings by Ferrari Richard, all Form 4s, filed between Feb 21, 2025 and Oct 9, 2026. Those filings report 13 transactions, from Feb 14, 2025 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ferrari Richard's filings is in SANTA CLARA, CA.
Recent filings by Ferrari Richard
- Oct 2, 2026: Grants or awards of BEAT derivative securities (3 lines, Form 4, code A).
- Jul 31, 2026: Option exercise of TNON shares (Form 4, code M).
- Jun 5, 2026: Grant or award of LUNG shares (Form 4, code A).
- Apr 16, 2026: Open-market purchases of BEAT shares (2 lines, Form 4, code P).
- Feb 9, 2026: Grant or award of BEAT shares (Form 4, code A).
Other insiders filing for HeartBeam, Inc. (BEAT)
- Elfrink Willem, Director
- JAFF MICHAEL R, Director
- Ortigas-Wedekind Marga, Director
- Nelson Kenneth Warwick III, Director
- de Urioste George, Director
- Persen Kenneth Harry, Chief Technology Officer